SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peng Yang, Gang Wang, Hongjun Huo, Qiang Li, Yan Zhao, Yuanhang Liu, SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial–mesenchymal transition via ERK and PI3K/AKT pathway, Medical Oncology, 2015, 32, 1

    CrossRef

  2. 2
    Jinhua Chen, Wenfang Wang, Hongyuan Wang, Xinyong Liu, Xiuli Guo, Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis, Drug Discoveries & Therapeutics, 2014, 8, 1, 33

    CrossRef

  3. 3
    Agnieszka Żuryń, Anna Litwiniec, Anna Klimaszewska-Wiśniewska, Jakub Marcin Nowak, Lidia Gackowska, Bartosz Jakub Myśliwiec, Andrzej Pawlik, Alina Grzanka, Expression of cyclin D1 after treatment with doxorubicin in the HL-60 cell line, Cell Biology International, 2014, 38, 7
  4. 4
    Yung Hyun Choi, Dong Yeok Shin, Wun-Jae Kim, Inhibition of Migration and Invasion of LNCap Human Prostate Carcinoma Cells by Doxorubicin through Inhibition of Matrix Metalloproteinase Activity and Tightening of Tight Junctions, Journal of Life Science, 2014, 24, 6, 700

    CrossRef

  5. 5
    Mohamed K. Al-Sadoon, Danny M. Rabah, Gamal Badr, Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: Molecular targets for cell cycle arrest and apoptosis induction, Cellular Immunology, 2013, 284, 1-2, 129

    CrossRef

  6. 6
    Gamal Badr, Mohamed K. Al-Sadoon, Danny M. Rabah, Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models, Free Radical Biology and Medicine, 2013, 65, 175

    CrossRef